Daré Bioscience, Inc.
Clinical trials sponsored by Daré Bioscience, Inc., explained in plain language.
-
New gel aims to zap persistent HPV in women
Disease control Not yet recruitingThis study tests whether a gel called DARE-HPV can clear a persistent high-risk HPV infection in the genital area. About 118 premenopausal women aged 22-50 with a long-lasting infection will receive one of two doses of the gel for 14 or 21 days, or a placebo. The main goal is to …
Phase: PHASE2 • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated May 26, 2026 10:32 UTC
-
New vaginal ring could help prevent early births – first human tests begin
Knowledge-focused Not yet recruitingThis early-stage study tests a new vaginal ring that releases the hormone progesterone. Researchers want to see how much progesterone gets into the blood over 14 days. The study involves 60 healthy postmenopausal women and compares two ring doses to a standard insert. This is not…
Phase: PHASE1 • Sponsor: Daré Bioscience, Inc. • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC